无注气经颈侧腔镜胸锁乳突肌后下入路在甲状腺手术中的应用

The application of transcervical non-inflatable endoscopic posterior inferior sternocleidomastoid approach in thyroid surgery

目的:探讨无注气经颈侧腔镜胸锁乳突肌后下入路甲状腺手术的临床疗效与安全性。方法:回顾性分析2022年12月至2023年5月收治的35例行无注气经颈侧腔镜胸锁乳突肌后下入路甲状腺乳头状癌手术患者,其中男14例,女21例,平均年龄44.7岁,记录患者手术时间、出血量、术后恢复、并发症及随访情况。结果:35例患者均顺利完成手术,平均手术时间4 h 7 min,平均出血量14 mL,平均术后住院时间3.5 d,无严重并发症,术后随访未诉明显颈部不适。结论:无注气经颈侧腔镜胸锁乳突肌后下入路甲状腺手术安全性良好,患者术后恢复快,外观满意度高,颈部舒适感好。

Objective:To investigate the clinical efficacy and safety of transcervical non-inflatable endoscopic thyroidectomy through the posterior inferior sternocleidomastoid approach.Methods:From December 2022 to May 2023,the clinical data of 35 patients with papillary thyroid carcinoma treated by transcervical non-inflatable endoscopic surgery via posterior inferior sternocleidomastoid approach were retrospectively analyzed.There were 14 males and 21 females,with an average age of 44.7 years.The operation time,bleeding volume,postoperative recovery,complications and follow-up were recorded.Results:All 35 patients successfully completed the surgery,with an average operation time of 4 hours and 7 minutes,an average bleeding volume of 14 ml,and an average postoperative hospital stay of 3.5 days.There were no serious complications and no obvious neck discomfort during postoperative follow-up.Conclusion:Transcervical non-inflatable endoscopic thyroidectomy via posterior inferior sternocleidomastoid approach is safe and effective,with fast postoperative recovery,high appearance satisfaction and good neck comfort.